Table 1. ANOVA (Main Effects and Interaction) Results of c-Fos Expression by Regions Tested.

	Condition ME		Drug ME		Condition × Drug
	F (2,53)	P	F (1,53)	P	F (2,53)	P
Prefrontal Cortex
PRL	0.09	0.97	19.41	***	0.60	0.55
ORF	0.91	0.40	13.60	***	0.54	0.58
CG2	1.48	0.23	27.94	***	1.27	0.29
Striatum
dmCPu	2.28	0.11	63.13	***	3.81	*
dlCPu	1.42	0.25	6.11	*	4.09	*
vmCPu	4.07	*	49.46	***	3.51	*
vlCPu	0.86	0.42	6.02	*	2.08	0.13
ACBc	3.76	*	48.17	***	0.92	0.4
ACBsh	1.02	0.36	35.02	***	1.98	0.14
Hippocampus
CA1	2.13	0.12	10.00	**	0.16	0.85
CA2	1.54	0.22	1.57	0.21	0.99	0.37
CA3	1.83	0.17	0.89	0.34	0.98	0.38
DG	2.44	0.09	0.02	0.88	0.85	0.43
Amygdala
CEM	0.32	0.72	11.87	**	0.09	0.90
BLA	1.10	0.33	27.25	***	1.04	0.35
MEAD	0.09	0.90	9.76	**	2.65	0.08
Other areas
VP	2.29	0.11	27.76	***	1.09	0.34
VTA	2.23	0.11	10.45	**	1.29	0.28
SNR	0.01	0.98	1.12	0.29	2.79	0.07

^*P<0.05, ^**P<0.01, ^***P<0.001.